We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

April 1, 2022

Building a digital health ecosystem - The key takeaways from our global gathering in Basel

Commentary
Philip Connolly
&

Building a digital health ecosystem - The key takeaways from our global gathering in Basel 

What does it take to build and sustain a digital health ecosystem? How can we create successful business models? 

As guests of Roche, 65 leaders of the HealthXL community joined us at their auditorium on Grenzacherstrasse in Basel to take a deep dive into these questions. 

It proved a meaty topic. The 2020 merger of Teladoc and Livongo showed us that virtual care platform play has arrived. While the industry recognizes the importance of shifting to a more patient-centric approach, questions remain about creating scalable and sustainable commercialization models.

We began the day with a series of presentations by experts in the field to provoke some thoughts, before moving into roundtable discussions as leaders and innovators from a variety of backgrounds shared their views.

We asked each roundtable to send us some of their key takeaways, which have been consolidated and edited for clarity.   

Leave no one behind - mapping an ecosystem

We must understand the value proposition of the ecosystem for all stakeholders deeply and test our hypothesis before drawing conclusions.

As the digital health ecosystem grows, we need to understand components that already exist, what the vision for the ecosystem is, and where every stakeholder fits into that vision. Investors could be potential curators of an ecosystem. 

There will never be one full platform solution that covers everything in healthcare, but there will be several different structures. These structures could then communicate with a central piece.

The entire patient journey, in any given indication, must be accounted for, alongside the responsible parties for each stage and reimbursement models for every stakeholder. 

Often, there is no need to build platforms outright, but rather to allow them to grow in both functionality and breadth over time based on patient needs and the market, such as with the Livongo and Teledoc merger.

Big problems can’t be solved in isolation - the importance of partnerships 

To build more comprehensive platforms, there is still a question about how to connect the ecosystem in a mutually beneficial way, rather than creating point-solutions-as-a-service business models. Business models need to derive from point solutions and evolve.

Compliance requirements prevent pharma from developing platforms in the middle, so someone else must drive the platform development. 

Big tech may have a role to play here, as they are already adept at complex technology solutions. However, there may be some trust issues to get past to bring them visibly into overall health solutions.

There is power in building on network effects and leveraging support from existing players in starting small in selected indications and building out contiguously – think about how Google drove vans one street at a time to execute a plan that would eventually map out entire cities.

It’s all about the user - being patient-centric

User experience must be central to all of our conversations - how do you increase your customer lifetime value? 

Platforms must be driven by improving patient outcomes, and the reason to build a platform is to be able to scale these outcomes.

The trick is to be trusted by patients, curate the best solutions to surround them with a continuum of care. 

To do this, we must facilitate a two-way interface with patients to properly involve them, deliver true personalization and collect evidence of effective treatments. This evidence can then be used to convince payors and change pathways.

The devil is in the detail - building a standard 

As a growing, and relatively young, ecosystem, there is a need for support data and other standardization to set standards and new ways of working. 

Our ecosystem should learn from other industries how they define standards and manage integration.

At the moment, outcomes tend to focus on illness versus wellness - what is the pharmacoeconomic argument to drive the standardization of outcomes based on health?

Want to join the conversation? Check out our website for upcoming meetings and events. 

Interested in more expert insights and takeaways? Become a member of our HealthXL Community for access to polls and summaries from all of our meetings.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Standing Out from the Crowd in Economic Recession

14th February @ 10:45AM EDT

The digital health industry has seen a decline in funding in recent times, as investors have become more knowledgeable and selective to where they allocate their capital. Seats are limited so apply now to secure your place.

Featuring
Jeremy Sohn
Jeremy Sohn
Managing General Partner, P74 Ventures
Featuring
Jeremy Sohn
Jeremy Sohn
Managing General Partner, P74 Ventures
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Endpoints and Control Arms in Trials for DTx

15th February @ 10:45AM EDT

Proving clinical efficacy is one of the biggest challenges for DTx companies. Apply now to join HealthXL in this session to dive deeper into this topic with leaders in this field.

Featuring
Acacia Parks
Acacia Parks
Chief Science Officer, Twill
Featuring
Acacia Parks
Acacia Parks
Chief Science Officer, Twill
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

The Role of the Consumer Experience in DTx

15th February @ 10:45AM EDT

As technology advances in all sectors (e.g. fintech, entertainment, etc), consumer behaviour changes and the expectations on user experience are higher than before. Apply now to secure your place in this meeting where you will dive deeper into this topic with your peers.

Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wireVentures
Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wireVentures
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Incorporating Extended Reality (XR) in Physician's’ Daily Work

28th February @ 10:45AM EDT

The healthcare industry is undergoing a digital transformation and extended reality (XR) technologies such as virtual reality (VR) and augmented reality (AR) are expected to play a significant role in this change in the next few years. Apply now to join this Masterclass led by Nemanja Kovačev, MedTech Expert at HTEC Group.

Featuring
Nemanja Kovačev
Nemanja Kovačev
MedTech Expert, HTEC Group
Featuring
Nemanja Kovačev
Nemanja Kovačev
MedTech Expert, HTEC Group

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Health Meeting
7th February @ 10:45AM EDT

Product Differentiation for Digital Health Solutions in the Cardiometabolic Disease Area

In the past few years, digital health solutions have proven to be helpful in preventing and managing cardiometabolic diseases remotely, leading to better  health outcomes and less hospitalizations, emergency visits, and in-office visits.

Jenn Roberts
Featuring
Jenn Roberts
Vice President Employer Health Strategy, Hello Heart
Telemedicine & Virtual Care Delivery
9th February @ 10:45AM EDT

Business Opportunities for Digital Health in Autoimmune Conditions: Upcoming Blockbuster Drugs

Millions of people worldwide suffer from autoimmune conditions such as rheumatoid arthritis (RA), psoriasis, lupus, Crohn's disease, multiple sclerosis, atopic dermatitis, to name a few. Join this meeting to deep dive into this topic in the Immunology Meeting Series. Seats are limited so apply now to secure your place.

Erik Janssen
Featuring
Erik Janssen
VP Global Digital Care Transformation Immunology, UCB
Digital Therapeutics (DTx)
14th February @ 10:45AM EDT

Masterclass: Standing Out from the Crowd in Economic Recession

The digital health industry has seen a decline in funding in recent times, as investors have become more knowledgeable and selective to where they allocate their capital. Seats are limited so apply now to secure your place.

Jeremy Sohn
Featuring
Jeremy Sohn
Managing General Partner, P74 Ventures
Digital Therapeutics (DTx)
15th February @ 10:45AM EDT

Masterclass: Endpoints and Control Arms in Trials for DTx

Proving clinical efficacy is one of the biggest challenges for DTx companies. Apply now to join HealthXL in this session to dive deeper into this topic with leaders in this field.

Acacia Parks
Featuring
Acacia Parks
Chief Science Officer, Twill

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.